Publications by authors named "Robert Wilhelm Koivula"
Commun Med (Lond)
January 2024
Article Synopsis
- Precision medicine can enhance the prediction of cardiovascular disease (CVD) risk in individuals with Type 2 diabetes (T2D), based on a systematic review of various studies.
- Out of 9380 studies, 416 met criteria, focusing on biomarkers, genetic markers, and risk score/models to find new prognostic factors.
- Only 13 biomarkers improved prediction, with NT-proBNP showing the strongest evidence, while other markers like troponin-T and triglyceride-glucose also showed moderate promise, highlighting a need for further research in this area.
Article Synopsis
- The study reviews the potential of precision medicine to enhance cardiovascular disease risk prediction in people with type 2 diabetes by analyzing long-term research studies.
- Out of 9380 studies, only 416 met the criteria for inclusion, with a focus on biomarkers, genetic markers, and risk models; 13 showed significant improvement in prediction.
- The most effective predictors identified were NT-proBNP, troponin-T, TyG index, and Genetic Risk Score for Coronary Heart Disease, although the overall findings indicate a need for more rigorous research to establish practical clinical applications.
